Literature DB >> 20051354

Distinct neural pathways mediate α7 nicotinic acetylcholine receptor-dependent activation of the forebrain.

Morten S Thomsen1, Anders Hay-Schmidt, Henrik H Hansen, Jens D Mikkelsen.   

Abstract

alpha(7) nicotinic acetylcholine receptor (nAChR) agonists are candidates for the treatment of cognitive deficits in schizophrenia. Selective alpha(7) nAChR agonists, such as SSR180711, activate neurons in the medial prefrontal cortex (mPFC) and nucleus accumbens shell (ACCshell) in rats, regions important for cognitive function. However, the neural substrates involved in these effects remain elusive. Here we identify cortically projecting cholinergic neurons in the horizontal limb of the diagonal band of Broca (HDB) in the basal forebrain (BF) as important targets for alpha(7) nAChR activation, as measured by c-Fos immunoreactivity, a marker of neuronal activation. Selective depletion of these cholinergic neurons abolishes the SSR180711-induced activation of the mPFC but not the ACCshell, demonstrating their critical importance for alpha(7) nAChR-dependent activation of the mPFC. Contrarily, selective depletion of dopaminergic neurons in the ventral tegmental area abolishes the SSR180711-induced activation of the ACCshell but not the mPFC or HDB. These results demonstrate 2 distinct neural pathways activated by SSR180711. The BF and mPFC are important for attentional function and may subserve the procognitive effects of alpha(7) nAChR agonists, whereas activation of the ACCshell is implicated in the beneficial effect of antipsychotics on the positive symptoms of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20051354     DOI: 10.1093/cercor/bhp283

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  12 in total

Review 1.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 2.  Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.

Authors:  Jared W Young; Mark A Geyer
Journal:  Biochem Pharmacol       Date:  2013-07-12       Impact factor: 5.858

3.  Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: reversal with an α7 nicotinic agonist.

Authors:  Julie M Brooks; Michelle L Pershing; Morten S Thomsen; Jens D Mikkelsen; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

4.  Olfactory discrimination varies in mice with different levels of α7-nicotinic acetylcholine receptor expression.

Authors:  Jennifer L Hellier; Nicole L Arevalo; Megan J Blatner; An K Dang; Amy C Clevenger; Catherine E Adams; Diego Restrepo
Journal:  Brain Res       Date:  2010-08-13       Impact factor: 3.252

5.  Nicotine administration in the cholinergic basal forebrain increases alcohol consumption in C57BL/6J mice.

Authors:  Rishi Sharma; Pradeep Sahota; Mahesh M Thakkar
Journal:  Alcohol Clin Exp Res       Date:  2014-02-11       Impact factor: 3.455

6.  α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia.

Authors:  Gilda A Neves; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-04-19       Impact factor: 7.853

7.  Axonal varicosity density as an index of local neuronal interactions.

Authors:  Zi-Wei Zhang; Jun Il Kang; Elvire Vaucher
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

8.  Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.

Authors:  Darlene H Brunzell; J Michael McIntosh
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

9.  Multiple amygdaloid divisions of arcopallium send convergent projections to the nucleus accumbens and neighboring subpallial amygdala regions in the domestic chicken: a selective pathway tracing and reconstruction study.

Authors:  János Hanics; Gyöngyi Teleki; Alán Alpár; Andrea D Székely; András Csillag
Journal:  Brain Struct Funct       Date:  2016-04-06       Impact factor: 3.270

10.  Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development.

Authors:  Dean T Acheson; Elizabeth W Twamley; Jared W Young
Journal:  Front Neurosci       Date:  2013-06-18       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.